Targeting stroma to treat cancers
نویسندگان
چکیده
منابع مشابه
Targeting Both Tumor and Stroma Cells to Treat Melanoma: NIPAWILMA.
All patients enrolled in either phase I or phase II will be treated according to the following treatment plan: Week 1–24: Chemotherapy with paclitaxel combined with nintedanib/placebo Week 25–48: Extended monotherapy with nintedanib/placebo Week 52 (or approximately 4 weeks after last treatment dose): End-of-treatment visit. Follow up: After end of treatment the survival, disease status and fur...
متن کاملTargeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers
The tumor microenvironment has been suggested to participate in tumorigenesis, but the nature of the communication between cancer cells and the microenvironment, especially in response to anticancer drugs, remains obscure. We determined that activation of the CCAAT/enhancer binding protein delta (CEBPD) response to Cisplatin and 5-Fluorouracil in cancer-associated macrophages and fibroblasts co...
متن کاملNew Strategies to Direct Therapeutic Targeting of PML to Treat Cancers
The tumor suppressor function of the promyelocytic leukemia (PML) protein was first identified as a result of its dysregulation in acute promyelocytic leukemia, however, its importance is now emerging far beyond hematological neoplasms, to an extensive range of malignancies, including solid tumors. In response to stress signals, PML coordinates the regulation of numerous proteins, which activat...
متن کاملTargeting Interferon- to Treat Atherosclerosis
The chronic inflammatory nature of atherosclerotic disease is now widely appreciated. Abnormal deposition and oxidative modification of serum lipoproteins in arterial walls stimulates the recruitment of monocytes and their conversion into foam cells. Concurrently, both innate and adaptive immune responses are induced. Cytokines and growth factors produced as part of these responses lead to the ...
متن کاملTargeting Glycosphingolipid Metabolism to Treat Kidney Disease.
The enhanced expression of glucosylceramide-based glycosphingolipids (GSLs) is a hallmark of many forms of renal disease including diabetic nephropathy, polycystic kidney disease and renal cell carcinoma. A common feature of each of these renal disorders is the preference metabolism via aerobic glycolysis. While aerobic glycolysis is an inefficient way to generate ATP, aerobic glycolysis promot...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Seminars in Cancer Biology
سال: 2012
ISSN: 1044-579X
DOI: 10.1016/j.semcancer.2011.12.008